IP Library Granted Patent US 8,530,177
Granted Patent B2
US 8,530,177 · App. 13/171,599 · Granted Sep 10, 2013

Chloral hydrate detection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,530,177
App. No.
13/171,599
Granted
Sep 10, 2013
Kind
B2
Abstract

The invention relates to an immunoassay method and kit for the indirect detection of chloral hydrate. The invention is underpinned by a novel immunogen that produces an antibody that is specific for the chloral hydrate metabolite trichloroethanol glucuronide. Detection and quantification of trichloroethanol glucuronide has important applications in clinical toxicology, drug facilitated crime, water testing and solvent exposure.

Claims (12)

1. A method of detecting and/or quantifying trichloroethanol glucuronide (TCG) in an individual or a solution, the method comprising contacting an in vitro sample taken from the individual or a solution with a conjugate and an antibody that specifically binds to TCG, wherein said antibody generated against an immunogen of the structure

where n=0 or 1; and where, when n=1, the crosslinker joins the carbonyl substituent of the tetrahydropyran ring to an antigenicity conferring carrier material (accm), and said antibody has less than 0.69% cross-reactivity to chloral hydrate, trichloroacetic acid and ethyl glucuronide as compared to reactivity of TCG, detecting the bound conjugate, and deducing from a calibrator value or calibrator values the presence or amount of TCG.

2. The method of claim 1 in which the in vitro sample is urine.

3. The method of claim 1 wherein said antibody is generated against an immunogen of the structure

in which n=1 and the crosslinker is —X—Y—Z—,

where X is a heteroatom selected from nitrogen, oxygen or sulphur;

Y is a C 1 -C 10 substituted or unsubstituted straight chain alkylene moiety, or arylene moiety; and

Z, before conjugation with the accm, is selected from a carboxy, a dithiopyridyl, a maleimide, an amino, a hydroxyl, a thiol, a thioester or an aldehyde moiety.

4. The method of claim 1 wherein said antibody is generated against an immunogen of the structure

in which n=0 and the accm is selected from bovine serum albumin, egg ovalbumin, bovine gamma globulin, bovine thyroglobulin or keyhole limpet haemocyanin.

5. The method of claim 1 wherein said antibody is generated against an immunogen of the structure

in which n=0 and the accm is bovine thyroglobulin.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVENYANCE PREVIOUSLY RECORDED AT REEL: 055950 FRAME: 0471. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 20, 2021
From: RANDOX LABORATORIES LIMITED
To: NORTHERN BANK LIMITED
Reel/Frame 056210/0055 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2021
From: RANDOX LABORATORIES LIMITED
To: NORTHERN BANK LIMITED
Reel/Frame 055950/0471 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2011
From: BENCHIKH, ELOUARD; MCCONNELL, IVAN; FITZGERALD, PETER; LOWRY, PHILIP
To: RANDOX LABORATORIES LIMITED
Reel/Frame 026772/0482 →